Flat dose regimens in two studies (nivolumab 20 mg or 100 mg once every 3 weeks and ... Two reviewers independently evaluated the quality of the studies by inspecting different components: generation ...

And, does nivolumab provide any disease free survival benefit in ... of which we will be unsure of the contribution from the neoadjuvant and adjuvant components of treatment: Dr. Plimack notes that ...

SAN FRANCISCO -- Post-surgical adjuvant nivolumab (Opdivo) improved survival outcomes in muscle-invasive bladder cancer (MIBC), regardless of the use of neoadjuvant chemotherapy, according to ...

Dr. Daniel Leonard (Medicine): A 65-year-old woman was transferred to this hospital for evaluation of pancytopenia and back pain. The patient had been in her usual state of health until 3 weeks ...

Thredd's assured solution accelerates the development and delivery of consumer and corporate payments components embedded within digital banks, as well as for expense management, B2B payments, crypto, ...

and analysis of breath for volatile organic components. These techniques need more validation by further studies.

Among the general data from the CheckMate 649 trial (NCT02872116) of nivolumab plus chemotherapy, he touched on the continuing debate of using combined positive score (CPS) of PD-L1 as a cut-off, as ...

The FDA is conducting a priority review of nivolumab plus ipilimumab for the first-line treatment of patients with unresectable or metastatic MSI-H/dMMR colorectal cancer. The FDA has accepted a ...

An expert discusses how the updated results from CheckMate 274 (Galsky 2025) include updated disease-free survival (DFS) and interim overall survival (OS), along with other key end points such as ...